Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Chinese Patent Office
Mallinckrodt
Argus Health
Colorcon
Johnson and Johnson

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 7,384,653

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,384,653
Title:Oral dosage form comprising a therapeutic agent and an adverse-effect agent
Abstract: The present invention provides an oral dosage form comprising a first composition and a second composition. The first composition comprises an effective amount of a therapeutic agent and the second composition comprises an effective amount of an adverse-effect agent. The adverse-effect agent is covered with a coating that is substantially insoluble in the gastrointestinal tract. In one embodiment, the adverse-effect agent is coated with an outer base-soluble layer and an inner acid-soluble layer. The therapeutic agent can be uncoated or can be coated with a coating having an outer acid-soluble layer and an inner base-soluble layer. The dosage form discourages administration of the therapeutic agent by other than oral administration.
Inventor(s): Wright, IV; Curtis (Norwalk, CT), Carpanzano; Anthony E. (Sherman, CT)
Assignee: Purdue Pharma L.P. (Stamford, CT)
Application Number:10/948,575
Patent Claims:see list of patent claims

Details for Patent 7,384,653

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up Purdue Pharma L.P. (Stamford, CT) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up Purdue Pharma L.P. (Stamford, CT) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up Purdue Pharma L.P. (Stamford, CT) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 001 2015-01-23 ➤ Sign Up Purdue Pharma L.P. (Stamford, CT) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 7,384,653

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 03013538 Feb 20, 2003
United States of America 2003044458 Mar 06, 2003
United States of America 2005063909 Mar 24, 2005
United States of America RE45822 Dec 22, 2015
Slovenia 1414459 Apr 30, 2010
Russian Federation 2004106620 Apr 10, 2005
Portugal 1414459 Mar 03, 2010
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cipla
AstraZeneca
Fish and Richardson
Julphar
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.